Lakeshore Biopharma Co Ltd's ability to collect accounts receivable sequentially worsen to 1.68, indicating more challenging environment then in the third quarter 2024, but still, it is a far cry from any concerns. Lakeshore Biopharma Co Ltd's Accounts Receivable average collection period in the Mar 31 2024 quarter, has increased to 217 days, from 180 days, in the 0 quarter.

If we take a look into Healthcare sector 544 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2024 from 0 to 3504.

What is Receivable Turnover Ratio?
What is Lakeshore Biopharma Co Ltd Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

LSB Receivables Turnover Ratio	(Mar 31 2024) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Mar 31 2023) IV. Quarter
Y / Y Receivable Change	-6.46 %	-7.1 %	-7.1 %	20.2 %	-
Y / Y Revenue Change	-19.18 %	-	-	-	-
Receivable Turnover Ratio (TTM)	1.68	2.03	1.98	1.94	1.94
LSB's Total Ranking	# 3504	# 0	# 0	# 0	# 0
Accounts Receivable average collection period days	217	180	184	188	188
Seq. Receivable Change	0.68 %	0 %	1360.62 %	-93.64 %	0 %
Seq. Revenue Change	-	-	-	-	-

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 195
Healthcare Sector	# 545
Overall Market	# 3504

Receivable Turnover Ratio Statistics
High	Average	Low
1.29	1.29	1.29
(Mar 31 2024)

LSB Company Profile • Back to LSB Efficiency Comparisons • Compare LSB Receivables Turnover Ratio to its Competitors

Financial Statements
Lakeshore Biopharma Co Ltd's Accounts Receivable	$ 63 Millions	Visit LSB's Balance sheet
Lakeshore Biopharma Co Ltd's Sales TTM	$ 81 Millions	Visit LSB's Income Statement
Sources of LSB's Revenues		Visit LSB's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
LSB's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
LSB's Growth Rates	LSB's Roa	LSB's Inventory Turnover Ratio	LSB's Dividend Comparisons
LSB's Profitability Ratios	LSB's Roi	LSB's Asset Turnover Ratio	LSB's Dividend Growth
LSB's Valuation Ratios	LSB's Roe	LSB's Financial Strength Ratios	LSB's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2024, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2024	Receivable at quarter ending Mar 31 2024
Macrogenics Inc	3.52	$ 43.357 Millions	$ 12.327 Millions
Eli Lilly And Company	3.52	$ 35,932.100 Millions	$ 10,221.225 Millions
Vyne Therapeutics Inc	3.50	$ 0.423 Millions	$ 0.121 Millions
Outset Medical Inc	3.49	$ 123.748 Millions	$ 35.463 Millions
Bridgebio Pharma Inc	3.48	$ 218.597 Millions	$ 62.757 Millions
Absci Corp	3.46	$ 5.347 Millions	$ 1.547 Millions
Cumberland Pharmaceuticals Inc	3.43	$ 38.826 Millions	$ 11.311 Millions
Retractable Technologies Inc	3.43	$ 39.586 Millions	$ 11.537 Millions
Nuo Therapeutics Inc	3.42	$ 0.782 Millions	$ 0.229 Millions
Docgo Inc	3.38	$ 735.150 Millions	$ 217.759 Millions
Ispecimen inc	3.36	$ 9.268 Millions	$ 2.761 Millions
Apyx Medical Corp	3.31	$ 49.566 Millions	$ 14.981 Millions
Sharecare Inc	3.29	$ 419.817 Millions	$ 127.682 Millions
Collegium Pharmaceutical Inc	3.21	$ 565.338 Millions	$ 175.887 Millions
Inspiremd Inc	3.21	$ 5.860 Millions	$ 1.828 Millions
2seventy Bio Inc	3.20	$ 71.201 Millions	$ 22.251 Millions
Avenir Wellness Solutions Inc	3.18	$ 4.575 Millions	$ 1.441 Millions
Royalty Pharma Plc	3.12	$ 2,238.561 Millions	$ 717.748 Millions
Aytu Biopharma Inc	3.10	$ 91.645 Millions	$ 29.537 Millions
Seer Inc	3.05	$ 14.814 Millions	$ 4.852 Millions
Establishment Labs Holdings Inc	3.04	$ 154.833 Millions	$ 50.961 Millions
Adc Therapeutics Sa	3.03	$ 68.619 Millions	$ 22.631 Millions
Ani Pharmaceuticals Inc	3.02	$ 517.460 Millions	$ 171.566 Millions
C4 Therapeutics Inc	2.98	$ 20.036 Millions	$ 6.732 Millions
Evofem Biosciences Inc	2.97	$ 16.012 Millions	$ 5.391 Millions
Axsome Therapeutics Inc	2.94	$ 251.023 Millions	$ 85.520 Millions
Assertio Holdings inc	2.92	$ 142.051 Millions	$ 48.587 Millions
Alimera Sciences Inc	2.84	$ 89.029 Millions	$ 31.325 Millions
Marker Therapeutics inc	2.82	$ 3.321 Millions	$ 1.177 Millions
Apellis Pharmaceuticals Inc	2.78	$ 524.070 Millions	$ 188.613 Millions

Date modified: 2026-06-22T16:58:57+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.